Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon (Q46578483)

23 December 2017

title

Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon (English)

1 reference

23 December 2017

0 references

Bojana Djordjevic

1

1 reference

23 December 2017

Wedad M Hanna

series ordinal

2

1 reference

23 December 2017

publication date

23 May 2008

1 reference

23 December 2017

published in

Modern Pathology

1 reference

23 December 2017

volume

21

1 reference

23 December 2017

issue

10

1 reference

23 December 2017

page(s)

1238-1245

1 reference

23 December 2017

Expression of c-kit proto-oncogene product in breast tissue.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

An update on molecular genetics of gastrointestinal stromal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Chronic myelogenous leukaemia--new therapeutic principles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Increased c-kit (CD117) expression in malignant mammary phyllodes tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Immunohistochemical studies of c-kit, transforming growth factor-beta, and basic fibroblast growth factor in mast cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Mast cells and eosinophils in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

The influence of host response on colorectal cancer prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Analysis of immune cell infiltrates during squamous carcinoma development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

7 January 2021

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

7 January 2021

CD34, CD117, and actin expression in phyllodes tumor of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

7 January 2021

p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.78

7 January 2021

10.1038/MODPATHOL.2008.78

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017